CD40LG and type 2 diabetes mellitus: Our research of these biomarkers showed significantly lower serum levels of ACIVAbs IgM, CIV-DP, CIC-CIV, and significantly higher levels of free ACIVAbs IgG in the T2D group compared to controls.